Sung-Gil Chi
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cell death mechanisms and regulation
Papers in
-
- TGF-β signaling in diseases 5
-
- NF-κB Signaling Pathways 7
- Co-authors
- Byung-Kyu Ryu (12 shared papers)Jong Seung Kim (7 shared papers)Min Goo Lee (7 shared papers)Hyo-Jong Kim (4 shared papers)Min-Goo Lee (7 shared papers)Andrea Alimonti (1 shared paper)Carlos Cordon‐Cardo (1 shared paper)Tom Misteli (1 shared paper)
- Journals
- Canadian Journal of Physiology and Pharmacology (3 papers)Oncogene (3 papers)Journal of Neuro-Oncology (2 papers)Cancer Research (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Sung-Gil Chi
69 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 574
- Molecular Biology 1.9k
- Oncology 551
- Cell Biology 250
- Immunology 291
Countries citing papers authored by Sung-Gil Chi
This map shows the geographic impact of Sung-Gil Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Gil Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Gil Chi more than expected).
Fields of papers citing papers by Sung-Gil Chi
This network shows the impact of papers produced by Sung-Gil Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Gil Chi. The network helps show where Sung-Gil Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sung-Gil Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression Hit paper breakdown → | 2007 | 593 |
| 2 | 2003 | 157 | |
| 3 | 2019 | 123 | |
| 4 | 2020 | 117 | |
| 5 | 2001 | 106 | |
| 6 | 2012 | 105 | |
| 7 | 2022 | 99 | |
| 8 | 2005 | 97 | |
| 9 | 2019 | 96 | |
| 10 | 2011 | 89 | |
| 11 | 2016 | 86 | |
| 12 | 2012 | 81 | |
| 13 | 2010 | 60 | |
| 14 | 1997 | 57 | |
| 15 | 2014 | 55 | |
| 16 | 2011 | 47 | |
| 17 | 2018 | 45 | |
| 18 | 2012 | 45 | |
| 19 | 2012 | 44 | |
| 20 | 2020 | 43 |
About Sung-Gil Chi
Sung-Gil Chi is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Immunology, having authored 72 papers that have together received 2.9k indexed citations. Recurring topics across this work include Caveolin-1 and cellular processes (8 papers), NF-κB Signaling Pathways (7 papers), Cancer-related Molecular Pathways (7 papers), Nanoplatforms for cancer theranostics (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), TGF-β signaling in diseases (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Cancer Research (574 citations), Molecular Biology (1.9k citations), Oncology (551 citations), Cell Biology (250 citations) and Immunology (291 citations). Sung-Gil Chi has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Byung-Kyu Ryu, Jong Seung Kim, Min Goo Lee, Hyo-Jong Kim, Min-Goo Lee, Andrea Alimonti, Carlos Cordon‐Cardo, Tom Misteli, Haijuan Yang and Xinjiang Wang. Their work appears in journals such as Canadian Journal of Physiology and Pharmacology, Oncogene, Journal of Neuro-Oncology, Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.